✦ LIBER ✦

Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma

✍ Scribed by Emel Yaman; Ugur Coskun; Banu Ozturk; Suleyman Buyukberber; Ali Osman Kaya; Ozlem Coskun; Nuray Buyukberber; Ramazan Yildiz; Mustafa Benekli

Book ID: 116674705
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 128 KB
Volume: 16
Category: Article
ISSN: 0967-5868
DOI: 10.1016/j.jocn.2008.05.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comment on “Opportunistic cytomegaloviru

Comment on “Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma”

✍ Konstantinos Gousias; Athanasios Kyritsis 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Corrigendum to “Comment on “Opportunisti

Corrigendum to “Comment on “Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma”” [Journal of Clinical Neuroscience (2010) 17, 412]

✍ Konstantinos Gousias; Athanasios Kyritsis 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Intravenous administration of temozolomi

Intravenous administration of temozolomide as a useful alternative over oral treatment with temozolomide capsules in patients with gliomas

✍ Kazuya Motomura; Atsushi Natsume; Toshihiko Wakabayashi 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 206 KB

Temozolomide/PLGA microparticles: a new

Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats

✍ Yu-Hui Zhang; He Zhang; Jian-min Liu; Zhi-Jian Yue 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 328 KB

Lenograstim for the treatment of neutrop

Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomised, placebo-controlled trial in AIDS patients

✍ M-L. Dubreuil-Lemaire; A. Gori; D. Vittecoq; G. Panelatti; F. Tharaux; R. Paliss 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Incidence of early pseudo-progression in

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

✍ Walter Taal; Dieta Brandsma; Hein G. de Bruin; Jacoline E. Bromberg; Annemarie T 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract ## BACKGROUND. Radiotherapy (RT) plus concomitant and adjuvant temozolomide (TMZ) is now the standard of care for patients with newly diagnosed glioblastoma. The occurrence of pseudo‐progression directly after RT is a recognized phenomenon, but to the authors' knowledge its incidence a